Knee Replacement Market to Reach USD 12.48 Billion by 2027; Rising Awareness about Early Diagnosis to Boost Market, states Fortune Business Insights™

    NEXT STORY
    OSE Immunotherapeutics To Present Step-1 Results of Phase 3 Clinical Trial of Tedopi® ‘Atalante 1’ in Non-Small Cell Lung Cancer at the European Society for Medical Oncology (ESMO) Virtual Congress 2020
    PREV STORY
    Immuneering to Present at the Inaugural LifeSci Partners Private Company Virtual Summer Symposium
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Histogenics Corporation to Announce Second Quarter 2017 Financial Results on August 10, 2017

    WALTHAM, Mass., July 27, 2017 (GLOBE NEWSWIRE) -- Histogenics Corporation (Nasdaq:HSGX), a regenerative medicine ...

    author_avatar
    NASDAQ Market News

    Atara Biotherapeutics Announces Presentations Highlighting Robust Off-the-Shelf, Allogeneic T-Cell Immunotherapy Pipeline and Next-Generation CAR T Technologies at the 60th American Society of Hematology (ASH) Annual Meeting and European Society for Medical Oncology (ESMO) Immuno-Oncology Congress 2018

    Moffitt Cancer Center collaborators to present next-generation chimeric antigen receptor T-cell (CAR T) technology ...

    author_avatar
    NASDAQ Market News

    Trillium Announces Voting Results From the Annual and Special Meeting of Shareholders

    author_avatar
    NASDAQ Market News